0.81 USD
▼-0.05-5.69%
盘后 0.85 0.00%
2026-11-20
市值
$83.64M
市盈率
—
EPS
-1.64
股息率
—
52 周区间
0.80 – 5.39
成交量
54.23K
Beta
1.02
目标价
2.80
52W 低 0.8052W 高 5.39
价格走势
公司简介
Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat obstructive sleep apnea. Its lead solution is the Genio system, a hypoglossal neurostimulations therapy for obstructive sleep apnea. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.